NCT07806539Completed
Hemodynamic Monitoring-Guided Goal-Directed Fluid Therapy in Robotic Radical Prostatectomy
Effectiveness of Goal-Directed Fluid Therapy Guided by Minimally Invasive Hemodynamic Monitoring in Robotic Radical Prostatectomy: A Prospective Observational Study
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
This prospective observational cohort study evaluated goal-directed fluid therapy guided by minimally invasive hemodynamic monitoring in adult male patients undergoing elective robotic radical prostatectomy. Patients were prospectively enrolled and followed according to the intraoperative fluid management strategy used in routine clinical practice. Patients managed with LiDCO®Rapid-guided goal-directed fluid therapy constituted the hemodynamic monitoring-guided group, while patients managed with conventional intraoperative fluid therapy constituted the control group. No randomization or additional research-related intervention was performed. The study compared the two fluid management strategies with respect to intraoperative crystalloid fluid administration and selected perioperative clinical and laboratory parameters.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 48 (actual)
- First submitted
- 25 Jun 2026
- Start date
- 23 Feb 2026
- Primary completion date
- 3 Jul 2026
- Lead sponsor
- Antalya Training and Research Hospital
- Diseases
- Prostate cancer, Stroke
- NCT number
- NCT07806539
What you commit to
- Study type: Observational
- Participants enrolled: 48
- From 23 Feb 2026 to the primary completion date, 3 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
Other illness
- Cardiac rhythm disturbances
- Severe valvular heart disease or active heart failure
- Pre-existing hematological conditions requiring planned blood transfusion
- Major peripheral vascular disease
- Chronic obstructive pulmonary disease
- Conditions associated with increased intra-abdominal pressure
Lab values
- Severe left ventricular dysfunction, defined as ejection fraction \<40%
- Chronic renal failure, dialysis dependency, or preoperative creatinine \>2 mg/dL
- Hemoglobin \<8 g/dL
Other
- Refusal to participate in the study
- Body mass index \>40 kg/m²
- Implanted pacemaker or implantable cardioverter-defibrillator
Who the study is looking for
- Male patients aged 18 to 80 years
- Patients scheduled for elective robotic radical prostatectomy
- American Society of Anesthesiologists physical status I-III
- Patients who provide written informed consent
Age in the registry: 18 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Antalya Training and Research Hospital Coordinator of this site? Confirm its status | Antalya | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.